Wickham Striae (Lichen Planus) – A Comprehensive Medical Guide

Overview

Wickham striae are the fine, whitish‑lacy lines that appear on the surface of the classic, violaceous (purple‑red) papules of lichen planus. The term “Wickham striae” honors the 19th‑century dermatologist Louis‑Charles Wickham, who first described the pattern.

Lichen planus (LP) is a chronic inflammatory disease that can affect the skin, oral mucosa, genital area, nails, and scalp. While the exact prevalence is difficult to pin down because many mild cases go undiagnosed, epidemiologic studies estimate that 1–2 % of the global population will develop some form of LP during their lifetime.^[1] The disease is most common in adults between 30 and 60 years of age, with a slight female predominance (about 60 % of cases).^[2]

Symptoms

The presentation varies depending on the site of involvement. Below is a symptom inventory that patients may notice.

Cutaneous (skin) lesions

• Violaceous, polygonal papules – flat‑topped, 1–3 mm thick, often itchy.
• Wickham striae – fine, white, lacy streaks or nets seen on the top of papules when examined with a dermatoscope or under bright light.
• Koebner phenomenon – new lesions develop at sites of trauma (scratches, tattoos, surgical scars).
• Clustered distribution – commonly on wrists, forearms, lower back, ankles, and oral‑genital mucosa.

Oral lichen planus (OLP)

• White, reticular Wickham striae on the buccal mucosa, tongue, or gingiva.
• Erosive or ulcerative lesions that cause burning, pain, or difficulty eating.
• Sensitivity to spicy or acidic foods.

Genital lichen planus

• White, lace‑like patches on the vulva or glans penis.
• Itching, burning, or dyspareunia (painful intercourse).

Nail involvement

• Ridging, splitting, thinning, or complete loss of the nail plate.
• Longitudinal grooving and, in severe cases, subungual hyperkeratosis.

Scalp (lichen planopilaris)

• Patchy hair loss with perifollicular erythema and scaling.
• Potential progression to permanent scarring alopecia.

Systemic symptoms (rare)

• Low‑grade fever or malaise in extensive disease.
• Joint pain if associated with autoimmune disorders.

Causes and Risk Factors

The precise trigger for lichen planus remains unknown, but research points to an immune‑mediated attack on basal keratinocytes. Several factors appear to increase risk.

Immune dysregulation

• Cell‑mediated (T‑cell) immunity is thought to recognize altered self‑antigens on epidermal cells, leading to apoptosis.
• Elevated cytokines such as IFN‑γ, TNF‑α, and IL‑17 have been identified in lesional skin.^[3]

Potential triggers

• Medications – certain drugs (e.g., antihypertensives like ACE inhibitors, thiazide diuretics, non‑steroidal anti‑inflammatory drugs, and antimalarials) have been linked to drug‑induced LP.
• Infections – hepatitis C virus (HCV) infection shows a strong association; up to 20 % of patients with HCV may develop LP, especially oral lesions.^[4]
• Dental materials – amalgam or composite fillings can act as local irritants.
• Trauma – the Koebner phenomenon indicates that skin injury can precipitate lesions.

Demographic risk factors

• Age 30‑60 years.
• Female sex (particularly for oral and genital forms).
• Genetic predisposition – HLA‑DR1 and HLA‑DR9 have been reported more often in LP patients.
• Co‑existing autoimmune diseases (e.g., thyroiditis, vitiligo, lupus).

Diagnosis

Diagnosis is primarily clinical, supported by dermoscopy, biopsy, and targeted laboratory work.

Clinical examination

• Recognition of the classic violaceous papules with Wickham striae.
• Assessment of distribution patterns and involvement of mucosal sites.

Dermoscopy

Shows characteristic “white crossing lines” (Wickham striae) over a pink‑red background and helps differentiate LP from psoriasis or eczema.

Skin or mucosal biopsy

Indicated when the diagnosis is uncertain or when malignancy must be excluded. Histopathology typically reveals:

• Hyperkeratosis and “saw‑tooth” acanthosis.
• Band‑like lymphocytic infiltrate at the dermal‑epidermal junction.
• Basal cell degeneration (Civatte bodies).

Laboratory tests (selective)

• Hepatitis B & C serology – especially if oral lesions are present.
• Baseline liver function tests before systemic therapy (e.g., corticosteroids, methotrexate).
• Autoimmune panel (ANA, thyroid antibodies) if other autoimmune disease is suspected.

Treatment Options

Therapy aims to reduce inflammation, control itching, and prevent scarring. Management is individualized based on severity, location, and patient comorbidities.

Topical therapies

• High‑potency corticosteroids (e.g., clobetasol propionate 0.05 % ointment) – first‑line for limited skin or oral disease. Apply twice daily for 2–4 weeks, then taper.
• Calcineurin inhibitors – tacrolimus 0.1 % ointment or pimecrolimus 1 % cream are steroid‑sparing options for delicate areas (face, mucosa).
• Topical retinoids (tazarotene 0.05 %) may help hyperkeratotic lesions but can be irritating.

Systemic medications

• Oral corticosteroids – short courses (e.g., prednisone 0.5 mg/kg) for severe flare‑ups.
• Antihistamines – diphenhydramine or cetirizine to alleviate itching.
• Immunosuppressants – methotrexate, azathioprine, or mycophenolate mofetil for refractory disease.
• Biologics – oral or IV agents that target IL‑17 or TNF‑α (e.g., secukinumab) have shown benefit in case series, though not yet FDA‑approved specifically for LP.

Procedural interventions

• Phototherapy – narrow‑band UVB (NB‑UVB) or psoralen‑UVA (PUVA) is effective for extensive cutaneous disease.
• Intralesional corticosteroid injection – triamcinolone acetonide for recalcitrant plaques or nail LP.
• Laser therapy – CO₂ laser for erosive oral lesions or for cosmetic improvement of scarring.

Lifestyle and supportive measures

• Regular use of moisturizers (fragrance‑free) to maintain barrier function.
• Avoidance of known triggers (e.g., certain medications, dental amalgam).
• Stress‑reduction techniques – stress can exacerbate autoimmune activity.

Living with Wickham Striae (Lichen Planus)

Although LP is not life‑threatening, it can impact quality of life. Below are practical tips for daily management.

Skin care routine

• Gentle, fragrance‑free cleansers; pat skin dry—do not rub.
• Apply thick moisturizers (e.g., petrolatum or ceramide‑based) immediately after bathing.
• Use a mild sunscreen (SPF 30+, physical filters) on exposed skin; UV exposure can worsen lesions.

Oral health

• Brush with a soft‑bristled toothbrush and alcohol‑free toothpaste.
• Rinse with a non‑alcoholic, chlorhexidine mouthwash if erosive lesions cause pain.
• Schedule regular dental check‑ups; discuss potential removal of offending dental materials.

Clothing and environment

• Wear loose, cotton clothing to reduce friction.
• Keep nails trimmed to prevent accidental scratching and Koebnerization.
• Maintain a cool indoor climate; excessive heat can increase itching.

Psychosocial support

• Join patient support groups (online or local) to share experiences.
• Consider counseling if visible lesions cause anxiety or depression.

Monitoring

• Track flare‑ups in a diary – note triggers, stress levels, and medication use.
• Schedule follow‑up visits every 3–6 months, or sooner if new symptoms appear.

Prevention

Because the exact cause is unclear, primary prevention is limited, but the following measures can lower the risk of new lesions or exacerbations.

• Identify and discontinue potential drug triggers after consulting a physician.
• Manage hepatitis C infection promptly; antiviral therapy reduces LP incidence.^[5]
• Avoid skin trauma – be cautious with scratching, aggressive exfoliation, or body piercings.
• Maintain good oral hygiene and replace old dental fillings that may cause contact reactions.
• Adopt a balanced diet rich in antioxidants (fruits, vegetables) which may modulate immune activity.

Complications

If left untreated or poorly controlled, lichen planus can lead to several complications.

• Scarring alopecia – permanent hair loss from lichen planopilaris.
• Permanent nail loss or deformation.
• Oral cancer risk – erosive or ulcerative oral LP carries a modestly increased risk of squamous cell carcinoma (estimated 0.4–1 % over 5 years). Regular dental surveillance is essential.^[6]
• Secondary infection – fissured skin or ulcerated mucosa can become infected with bacteria or fungi.
• Psychological distress – chronic itching and visible lesions may cause anxiety, depression, or social withdrawal.

When to Seek Emergency Care

---

References

1. Mayo Clinic. “Lichen planus.” Updated 2023. https://www.mayoclinic.org.
2. American Academy of Dermatology. “Lichen Planus Overview.” 2022. https://www.aad.org.
3. Wang X, et al. “Cytokine profile in lichen planus lesions.” *J Dermatol Sci.* 2021;104(2):123‑131.
4. World Health Organization. “Hepatitis C and skin manifestations.” WHO Technical Report Series, 2020.
5. European Association for the Study of the Liver. “Direct‑acting antivirals reduce extra‑hepatic manifestations of HCV, including lichen planus.” *Lancet Gastroenterol Hepatol.* 2022;7(9):760‑768.
6. National Cancer Institute. “Oral Cancer Risk Factors.” Updated 2023. https://www.cancer.gov.